Bora Pharmaceuticals Co., Ltd. (TPE:6472)
Taiwan · Delayed Price · Currency is TWD 444.50
+19.50 (4.59%)
Sep 18, 2026, 1:30 PM CST
Bora Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Bora Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $575.04. The average 1-year stock price forecast is 29.37% higher than the current stock price, while the lowest is $480.00 (+7.99%) and the highest is $729.29 (+64.07%).
Price Target: $575.04 (+29.37%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Bora Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 6 | 6 | 7 | 7 |
Financial Forecast
Revenue This Year
23.28B
from 19.01B
Increased by 22.45%
Revenue Next Year
29.11B
from 23.28B
Increased by 25.02%
EPS This Year
18.89
from 23.24
Decreased by -18.73%
EPS Next Year
35.10
from 18.89
Increased by 85.81%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is TWD.